No Data
No Data
BofA Cuts Price Target on Harmony Biosciences to $32 From $33
Bank of America Securities Sticks to Its Sell Rating for Harmony Biosciences Holdings (HRMY)
H.C. Wainwright Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $70
Oppenheimer Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $61
Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $50
Positive Outlook for Harmony Biosciences Holdings Based on Promising ZYN-002 Study Results